ESNT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Essent Group Ltd (ESNT) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has a mixed-to-bearish technical setup, no recent news catalyst, and insider selling has increased. Analyst sentiment is divided but still slightly constructive overall, with one Buy rating and multiple Neutral/Equal Weight views. Given the current data, the best direct call is to hold and wait for clearer trend improvement before buying.
ESNT is trading at 57.87, slightly below the previous close of 58.34. The technical picture is weak: MACD histogram is negative and worsening, which confirms bearish momentum. RSI_6 at 25.858 is deeply oversold, but not yet a strong reversal confirmation on its own. Moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, showing the broader trend is still under pressure. Key levels: support is near 57.91 (S2) and 58.847 (S1), while resistance begins at 60.363 (pivot) and extends to 61.88/62.817. The stock trend model suggests modest near-term upside probabilities, but the current setup does not look like a clean long-term entry for an impatient buyer.
["Options sentiment is strongly bullish based on the very low put-call ratios.", "Barclays raised its price target to $62 from $61.", "BofA raised its price target to $69 from $68 and maintained a Buy rating.", "The stock trend model suggests a 70% chance of modest gains over the next day, week, and month."]
["MACD is negative and worsening, indicating weakening momentum.", "Bearish moving average alignment suggests the broader trend is still down.", "Insiders are selling, and selling activity increased 184.94% over the last month.", "No recent news catalysts in the past week.", "JPMorgan and UBS remain Neutral, and Barclays is only Equal Weight despite a higher target."]
No usable latest-quarter financial snapshot was provided because the data returned an error. As a result, there is no reliable quarter-by-quarter revenue, EPS, or growth commentary available here. The latest quarter season was not provided in the dataset.
Analyst sentiment is mixed but not negative. Recent changes show Barclays raising its target to $62 while keeping Equal Weight, BofA raising its target to $69 and maintaining Buy, JPMorgan trimming its target to $64 while staying Neutral, and UBS lowering its target to $63 while staying Neutral. The overall Wall Street view is cautious-to-constructive: there is upside in targets, but most firms are not aggressively bullish. Pros: target increases and one Buy rating support valuation stability. Cons: multiple Neutral/Equal Weight ratings show limited conviction and imply the stock is not a high-conviction long-term buy at current levels.
